T 2464/10 (Anticoagulant protein/IMPERIAL) du 25.05.2012
- Identifiant européen de la jurisprudence
- ECLI:EP:BA:2012:T246410.20120525
- Date de la décision
- 25 mai 2012
- Numéro de l'affaire
- T 2464/10
- Requête en révision de
- -
- Numéro de la demande
- 05077712.7
- Classe de la CIB
- C12N 15/62
- Langue de la procédure
- Anglais
- Distribution
- Distribuées aux présidents et aux membres des chambres de recours (B)
- Téléchargement
- Décision en anglais
- Versions JO
- Aucun lien JO trouvé
- Autres décisions pour cet affaire
- -
- Résumés pour cette décision
- -
- Titre de la demande
- Anticoagulant fusion protein anchored to cell membrane
- Nom du demandeur
- Imperial Innovations Limited
- Nom de l'opposant
- -
- Chambre
- 3.3.08
- Sommaire
- -
- Dispositions juridiques pertinentes
- European Patent Convention Art 123(2)European Patent Convention Art 76(1)European Patent Convention R 28(b)European Patent Convention R 28(c)
- Mots-clés
- Main request: compliance with Articles 76(1) and 123(2) (yes)
- Exergue
- Remaining subject matter test of G 0002/10 applied. The Enlarged Board of Appeal in G 0002/10 did not consider that G 0001/03 provided an exhaustive treatment of the conditions under which an undisclosed disclaimer was to be allowable. In addition to the requirements set out in G 0001/03, G 0002/10 developed the further test of whether the skilled person would, using common general knowledge, regard the remaining claimed subject matter as explicitly or implicitly, but directly and unambiguously, disclosed in the application as filed.
ORDER
For these reasons it is decided that:
1. The decision under appeal is set aside.
2. The case is remitted to the examining division for further prosecution on the basis of claims 1 to 15 of the main request filed under cover of the letter of 10 April 2012.